News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Vor Biopharma (VOR) had its price target lowered by HC Wainwright from $32.00 to $31.00. They now have a "buy" rating on the stock.

Vor Biopharma (VOR) was upgraded by Wall Street Zen from "strong sell"

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Vor Biopharma (VOR) had its price target raised by Wedbush from $9.00 to $15.00. They now have a "neutral" rating on the stock.

Vor Biopharma (VOR) was upgraded by Jefferies Financial Group Inc. to "strong-buy".

3/30/2026

08:03 am

VOR

-0.7%

MISS

11/13/2025

04:01 pm

VOR

2.7%

MISS

8/12/2025

04:02 pm

VOR

1.0%

MISS

5/14/2025

04:02 pm

VOR

1.7%

MISS

Form S-3 Vor Biopharma Inc.

Form DEFA14A Vor Biopharma Inc.

Form ARS Vor Biopharma Inc. For: Dec 31

Form DEF 14A Vor Biopharma Inc. For: Apr 23

Form 4 Vor Biopharma Inc. For: Apr 22 Filed by: Kolchinsky Peter

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}